These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7479288)
41. Comparison in different tissue preparations of the in vitro pharmacological profile of RP 67580, a new non-peptide substance P antagonist. Carruette A; Moussaoui SM; Champion A; Cottez D; Goniot P; Garret C Neuropeptides; 1992 Dec; 23(4):245-50. PubMed ID: 1282222 [TBL] [Abstract][Full Text] [Related]
42. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists. Beaujouan JC; Heuillet E; Petitet F; Saffroy M; Torrens Y; Glowinski J Br J Pharmacol; 1993 Mar; 108(3):793-800. PubMed ID: 7682138 [TBL] [Abstract][Full Text] [Related]
43. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Hall JM; Flowers JM; Morton IK Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072 [TBL] [Abstract][Full Text] [Related]
44. Tachykinin NK1 receptors mediate both vasoconstrictor and vasodilator responses in the rabbit isolated jugular vein. Patacchini R; Maggi CA Eur J Pharmacol; 1995 Sep; 283(1-3):233-40. PubMed ID: 7498315 [TBL] [Abstract][Full Text] [Related]
45. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum. Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517 [TBL] [Abstract][Full Text] [Related]
46. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Picard P; Regoli D; Couture R Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304 [TBL] [Abstract][Full Text] [Related]
47. Highly potent substance P antagonists substituted with beta-phenyl- or beta-benzyl-proline at position 10. Lavielle S; Brunissen A; Carruette A; Garret C; Chassaing G Eur J Pharmacol; 1994 Jun; 258(3):273-6. PubMed ID: 7522179 [TBL] [Abstract][Full Text] [Related]
48. Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. Kemel ML; Pérez S; Godeheu G; Soubrié P; Glowinski J J Neurosci; 2002 Mar; 22(5):1929-36. PubMed ID: 11880523 [TBL] [Abstract][Full Text] [Related]
49. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Tremblay L; Kemel ML; Desban M; Gauchy C; Glowinski J Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11214-8. PubMed ID: 1280822 [TBL] [Abstract][Full Text] [Related]
50. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801. Beaujouan JC; Saffroy M; Torrens Y; Glowinski J Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606 [TBL] [Abstract][Full Text] [Related]
51. Depolarization evoked co-release of tachykinins from enteric nerves in the guinea-pig proximal colon. Lippi A; Santicioli P; Criscuoli M; Maggi CA Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):245-51. PubMed ID: 9550295 [TBL] [Abstract][Full Text] [Related]
52. Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice. Ravard S; Betschart J; Fardin V; Flamand O; Blanchard JC Brain Res; 1994 Jul; 651(1-2):199-208. PubMed ID: 7522932 [TBL] [Abstract][Full Text] [Related]
53. Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglion. Hawcock AB; Beresford IJ; Marshall FH; Hagan RM Eur J Pharmacol; 1995 Dec; 294(1):163-71. PubMed ID: 8788428 [TBL] [Abstract][Full Text] [Related]
54. Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors. Torrens Y; Beaujouan JC; Saffroy M; Glowinski J Biochem Biophys Res Commun; 2000 Apr; 270(2):668-72. PubMed ID: 10753681 [TBL] [Abstract][Full Text] [Related]
55. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct. Patacchini R; Barthó L; Maggi CA Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808 [TBL] [Abstract][Full Text] [Related]
56. Differences in the effects of NK1-receptor antagonists, (+/-)-CP 96,345 and CP 99,994, on agonist-induced responses in guinea-pig trachea. Longmore J; Razzaque Z; Shaw D; Hill RG Br J Pharmacol; 1994 May; 112(1):176-8. PubMed ID: 7518303 [TBL] [Abstract][Full Text] [Related]
57. Septide but not substance P stimulates inhibitory neurons in guinea-pig ileum. Burcher E; Stamatakos C Eur J Pharmacol; 1994 Jun; 258(3):R9-10. PubMed ID: 7522175 [TBL] [Abstract][Full Text] [Related]
58. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Petitet F; Saffroy M; Torrens Y; Lavielle S; Chassaing G; Loeuillet D; Glowinski J; Beaujouan JC Peptides; 1992; 13(2):383-8. PubMed ID: 1384010 [TBL] [Abstract][Full Text] [Related]
59. In vitro characterization of the non-peptide tachykinin NK1 and NK2-receptor antagonists, SR140333 and SR48968 in different rat and guinea-pig intestinal segments. Croci T; Emonds-Alt X; Le Fur G; Manara L Life Sci; 1995; 56(4):267-75. PubMed ID: 7529864 [TBL] [Abstract][Full Text] [Related]
60. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. Deschamps K; Couture R Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]